Dr Harriet Teare
|Tel||+44 (0)1865 287879|
- Centre for Health, Law and Emerging Technologies (HeLEX) Research Group
Deputy Director, HeLEX
Dr Harriet Teare’s research interests relate to the role of participants in medical research, and improving governance infrastructure to support communication and interactive engagement. She contributes to a number of specific research projects, including providing research governance and ethical support to the DIRECT project – an IMI-JU funded collaboration exploring stratification in Type 2 diabetes, the Rudy project – a research network for rare diseases of the blood, bone and joints, and leads a work package focusing on consent in the Genetics Clinic of the Future – a Horizon 2020 project mapping the complex challenges that will need to be tackled to introduce genome sequencing more widely into the clinic. Harriet obtained a DPhil in Chemistry from Merton College, Oxford, and previously worked as a senior policy advisor at Cancer Research UK, focusing on policy issues relating to science and research, and public health.
The RUDY study: using digital technologies to enable a research partnership.
Teare HJA. et al, (2017), Eur J Hum Genet, 25, 816 - 822
Dynamic Consent: a potential solution to some of the challenges of modern biomedical research.
Budin-Ljøsne I. et al, (2017), BMC Med Ethics, 18
Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia.
Forestier-Zhang L. et al, (2016), Orphanet J Rare Dis, 11
The RUDY study platform - a novel approach to patient driven research in rare musculoskeletal diseases.
Javaid MK. et al, (2016), Orphanet J Rare Dis, 11
Using digital technologies to engage with medical research: views of myotonic dystrophy patients in Japan.
Coathup V. et al, (2016), BMC Med Ethics, 17